Correction: Prognostic factors in patients with heart failure and sarcopenia: an observational retrospective study
Yasutaka Imamura, Atsushi Suzuki, Kazuho Kamishima, Kazuhito Suzuki, Junichi Yamaguchi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNutrition and Health in Aging
**Correction: The Egyptian Heart Journal (2024) 76:52 ** 10.1186/s43044-024-00484-4
Following publication of the original article [1], the authors identified the errors listed below.
- Section—Results, Subsection—Patients’ characteristics, Paragraph—2:“However, the HFpEF group tended to be older (p = 0.076), have a higher rate of smoking history (p = 0.058), and have a significantly higher rate of hypertension (p = 0.002).” needs to be changed to “However, the HFpEF group tended to be older (p = 0.076), have a lower rate of smoking history (p = 0.058), and have a significantly higher rate of hypertension (p = 0.002).”Text after correction:A comparison of the characteristics of patients with HFpEF and those with HFrEF did not show significant differences in age or body mass index. In addition, there were no differences in the rates of diabetes and hyperlipidemia between the two groups. However, the HFpEF group tended to be older (p = 0.076), have a lower rate of smoking history (p = 0.058), and have a significantly higher rate of hypertension (p = 0.002).
- Table 2, Row—Infection, Column—All patients (n = 256): “12 (26%)” needs to be changed to “11 (23%)”.Text after correction:Table 2. Causes of death among HFrEF and HFpEF patientsAll patients (n = 256)HFrEF (n = 83)HFpEF (n = 173)p-valueAll-cause death47 (18%)22 (27%)25 (14%)0.020Cardiovascular or cerebrovascular cause24 (51%)13 (59%)11 (44%)0.471Heart failure18 (38%)10 (45%)8 (32%)Ventricular arrhythmia or sudden death3 (6%)2 (9%)1 (4%)Myocarditis1 (2%)1 (5%)0 (0%)Aortic dissection1 (2%)0 (0%)1 (4%)Stroke1 (2%)0 (0%)1 (4%)Other cause23 (49%)9 (41%)14 (56%)Infection11 (23%)5 (23%)6 (24%)Malignancy5 (10%)2 (9%)3 (12%)other non-cardiac cause3 (6%)1 (5%)2 (8%)Unknown4 (9%)1 (5%)3 (12%)
- Table 3“eGFR per 10 mL/min/1.73 cm^2^ decrease” needs to be changed to “eGFR per 10 mL/min/1.73 m^2^ decrease”.“Albumin < 10 mmHg/dL” needs to be changed to “Albumin < 3.8 g/dL”Text after correction:Table 3. Univariate and multivariate analyses related to prognosisUnivariate analysisMultivariate analysisHR95% CIpHR95% CIp-valueMale sex0.9440.532–1.6730.843Age ≥ 85 years2.3161.270–4.2270.0062.4351.3104.5260.005NYHA functional class1.5431.061–2.2440.0231.6351.100–2.4290.015Ischemic etiology1.3180.738–2.3540.350HFrEF vs. HFpEF2.4691.383–4.4050.0022.0661.110–3.8610.022systolic BP per 10 mmHg decrease1.1070.995–1.2330.063albumin < 3.8 g/dL2.3410.922–5.9430.074eGFR per 10 mL/min/1.73 m^2^ decrease1.1350.999–1.2890.050Log BNP ≥ 2.53.4541.789–6.668 < 0.0012.8851.487–5.5960.002Beta-blocker0.9290.495–1.7420.818ACE inhibitor or ARB0.7190.379–1.3670.315
The original article [1] has been corrected.
The reference list from the paper itself. Each links out to its DOI / PubMed record.